期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 104, 期 12, 页码 4276-4286出版社
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.24666
关键词
chronic dermal toxicity; corticosteroids; chitosan; nanoparticles; nanotoxicology; nanoencapsulation; skin; targeted drug delivery; biodegradable polymers
资金
- Universiti Kebangsaan Malaysia [UKM-AP-2013-002]
Hydrocortisone (HC) is a topical glucocorticoid for the treatment of atopic dermatitis (AD); the local as well as systemic side effects limit its use. Hydroxytyrosol (HT) is a polyphenol present in olive oil that has strong antimicrobial and antioxidant activities. HC-HT coloaded chitosan nanoparticles (HC-HT CSNPs) were therefore developed to improve the efficacy against AD. In this study, HC-HT CSNPs of 235 +/- 9 nm in size and with zeta potential +39.2 +/- 1.6 mV were incorporated into aqueous cream (vehicle) and investigated for acute dermal toxicity, dermal irritation, and repeated dose toxicity using albino Wistar rats. HC-HT CSNPs exhibited LD50 > 125 mg/body surface area of active, which is 100-fold higher than the normal human dose of HC. Compared with the commercial formulation, 0.5 g of HC-HT CSNPs did not cause skin irritation, as measured by Tewameter (R), Mexameter (R), and as observed visually. Moreover, no-observed-adverse-effect level was observed with respect to body weight, organ weight, feed consumption, blood hematological and biochemical, urinalysis, and histopathological parameters at a dose of 1000 mg/body surface area per day of HC-HT CSNPs for 28 days. This in vivo study demonstrated that nanoencapsulation significantly reduced the toxic effects of HC and this should allow further clinical investigations. (C) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据